2700 Final results of ARIEL2 (Part 1): A phase 2 trial to prospectively identify ovarian cancer (OC) responders to rucaparib using tumor genetic analysis
暂无分享，去创建一个
R. Yelensky | A. Tinker | A. Oza | J. Brenton | C. Scott | E. Swisher | I. McNeish | R. Coleman | A. Leary | G. Konecny | S. Goble | M. Raponi | R. Kristeleit | K. Bell-McGuinn | A. Oaknin | D. O’Malley | L. Maloney | Kedan Lin | H. Giordano